Dr Reddy's Lab to Enter Japanese Market Through a Partner

Hyderabad: Pharmaceutical major Dr Reddy's Laboratories today said it has plans to enter Japanese market through partnerships for specific products.   G V Prasad, Co-chairman and CEO, also said the company may launch its first biosimilar drug in 2018.   "Japan is certainly on our target. We are developing products for Japan. But we will enter into this market through a partner. We don't intend to do direct presence there. We are loo...